Medosome Biotec LLC   Report issue

For profit Phase 3
Founded: Alachua FL United States (2015)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2016
NCT02690285
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

sodium dichloroacetate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pyruvate Dehydrogenase Complex Deficiency Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1